logo
  • Home
  • About Us
  • Cognition
  • Pipeline
  • News
  • Talent
  • Contact
中
  • Industry Trends
  • Technological Frontier
  • Information of YuanVore
Location: Home > News > Industry Trends
  • Nearly 40 stem cell clinical enterprises in China have made progress, and the third medical revolution is under way.
    15
    2023-08
    2023-08-15
  • 17 cell therapy companies in Shanghai received more than 2 billion yuan in financing
    15
    2023-08
    2023-08-15
  • Reconstructing structure, reproducing function, and constructing organ "substitute" -- 2023 Organoid Technology and Industry Research Report
    15
    2023-08
    2023-08-15
  • Stem cell induced organoid industry research report
    14
    2023-08
    2023-08-14
  • To increase efforts to attract foreign investment, The State Council recently issued a statement encouraging foreign-invested enterprises to carry out clinical trials of overseas listed cell and gene therapy drugs in China in accordance with the law.
    14
    2023-08
    2023-08-14
  • Domestic cell gene therapy product approval speed up
    14
    2023-08
    2023-08-14
  • 43 academicians speak highly of stem cells! The state has high hopes for the stem cell industry.
    11
    2023-08
    2023-08-11
  • China's future biomedicine industry deserves attention in the top 10 areas, gene editing, cell therapy, new drug delivery technology list.
    10
    2023-08
    2023-08-10
Prev
... 28 29 30 31 32 ...
Next
logo

Phone:021-64051958

Email:info@yuanvore.com

  • Cognition
    Cognition
    CellBank
    Platform
    Patent
  • Pipeline
    PipelineLayout
  • News
    Industry Trends
    Technological Frontier
    Information of YuanVore
  • Talent
    Enterprise Culture
    Job Information
  • About Us
    Contact Us
CopyRight @ 2023 Shanghai Yuanvore Medicine Technology Co., Ltd. AIl Rights Reserved 沪ICP备2023021701号

沪公网安备31011202020042号